These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4397054)

  • 21. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experience with a new adrenergic beta blockader (ICI 50.172) in coronary patients].
    Sánchez Cascos A
    Rev Esp Cardiol; 1971; 24(2):215-20. PubMed ID: 4400235
    [No Abstract]   [Full Text] [Related]  

  • 24. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a new beta blocking drug (butidrine) on some biohumoral indices, liver and kidney function and exercise tolerance.
    Barbi G; Tallone B
    Panminerva Med; 1969; 11(7):372-7. PubMed ID: 4390702
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C; Oztürk M
    Presse Med (1893); 1971 Apr; 79(17):765-6. PubMed ID: 4396515
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

  • 28. New dimension in angina pectoris therapy.
    Russek HI
    Geriatrics; 1969 Mar; 24(3):81-95. PubMed ID: 4885554
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical effect of beta receptor blockader in angina pectoris caused by coronary sclerosis].
    Schaller K
    Z Arztl Fortbild (Jena); 1970 Jul; 64(13):671-3. PubMed ID: 4398819
    [No Abstract]   [Full Text] [Related]  

  • 31. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

  • 32. [Beta-blocking drugs in cardiac therapy].
    Pretolani E
    G Clin Med; 1968 Feb; 49(2):221-8. PubMed ID: 4392710
    [No Abstract]   [Full Text] [Related]  

  • 33. [Anti-anginal action of a combination of a beta-blocking agent, butydrine, with a nitroderivative with prolonged action, pentaerythrite. Clinical evaluation].
    Cerri B; Bianchi G
    Clin Ter; 1969 Dec; 51(5):431-7. PubMed ID: 4392754
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experience with a combination of a new beta-blocking agent, LB 46, and quinidine in the treatment of chronic atrial fibrillation].
    Levi GF; Proto C
    Minerva Cardioangiol; 1972 Feb; 20(2):92-5. PubMed ID: 4401589
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current problems in the medical treatment of coronary insufficiency].
    Cunescu V; Pîrvu V
    Med Interna (Bucur); 1968 Aug; 20(8):899-905. PubMed ID: 4975788
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic possibilities in coronary disease].
    Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
    Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract]   [Full Text] [Related]  

  • 39. LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias.
    Storstein L
    Acta Med Scand; 1972 May; 191(5):423-8. PubMed ID: 4402323
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.